Navigation Links
NRI Scientists find Potential Colon Cancer Weapon

A five-member team of India-born medical researchers in the United States has discovered what may become a potent new weapon in the fight against colon cancer.//

The scientists from the University of Texas succeeded in stopping colon cancer growth in mice by halting the activity of a single enzyme called aldose reductase.

Blocking this enzyme shuts down the toxic network of biochemical signals that promotes inflammation and colon cancer cell growth, the scientists reported in the latest issue of journal Cancer Research.

They showed that blocking the production of aldose reductase halts the growth of human colon cancer cells implanted in laboratory mice.

"By inhibiting aldose reductase we were able to completely stop the further growth of colorectal cancer tumour cells," they said. Colon cancer is the second leading cancer killer in the US.

The team included senior author Satish Srivastava and his colleagues - Ravinder Tammali, Kota V. Ramana, Sharad S. Singhal and Sanjay Awasthi.

In their experiments on mice, the researchers implanted human colon cancer cells beneath the skin of "nude mice" - a hairless and immune-deficient variety commonly used in medical research.

Tumour progression stopped completely in the mice treated with genetic material known as small interfering RNA (or "siRNA") that was engineered to prevent cells from making the aldose reductase enzyme.

The treated mice seemed unharmed by the procedure. In contrast, the untreated control animals experienced uncontrolled tumour growth, they reported.

The researchers, however, point out that the gap between a brand new procedure that works in nude mice and one that works in humans is considerable.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ister has said that he would prefer not step in to...th services//. This idea was proposed during a mee...ans yesterday. A decade of talks between the New S...ments has still not revealed a common plan towards...
...isa Norris, 16 has succumbed to the accidental 17 ...stake was discovered//. Lisa Norris, from Girvan ...ctober last year. She was admitted to the Beatson ...argest cancer hospital, which has administered mor...
... Aberdeen University have found out molecules that...ses and other serious disorders//. The expression...r for vascular endothelial growth factor A, preven...n obstructing blood vessels, thus keeps the cornea...
... the capital has neither improved nor deteriorated...till hospitalized. For over a week, the number of...l Sciences (AIIMS) // has been about 175. The numb...g; however, the doctors cautioned that this might ...
Other Medicine News:Health News:Cancer patient Dies of Massive Radiation Overdose 2
(Date:9/4/2008)...he treatment of Acute Myeloid ...Newswire/ -- Celator Pharmaceuticals today,announc...has granted orphan,drug designation to CPX-351 (Cy...treatment of Acute Myeloid Leukemia (AML)., Celat...d Phase 2,studies with CPX-351. The first Phase 2 ...
(Date:9/4/2008)...-- Southern Research Institute,today announced tha...cted,the organization to participate in the newly-... Network (MLPCN). The MLPCN -- a collaborative,res...s Program which is,designed to benefit human healt...e and validate future targets for drug discovery.,...
(Date:9/4/2008)...on for Targeted Therapies That Ensure...BEACH, Calif., and AMSTERDAM, Netherlands, Sept. 4...lar cancer diagnostics,today announced the launch...ows physicians to quantitatively determine the gen... progesterone receptor (PR) and Human Epidermal,gr...
(Date:9/3/2008)...arch and Education Foundation,s Within Our Reach ... Treating and Understanding RA...time during its,unprecedented initiative to find a...ge of Rheumatology Research and Education Foundati...arch funded by the Within Our,Reach: Finding a Cur...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Melvin receives Salivary Research Award 22799 1Atchison receives Behavioral Epidemiological and Health Services Research Award 22796 1Atchison receives Behavioral Epidemiological and Health Services Research Award 22796 2Statewide Wellness Awards Competition Now Open for Nominations 22794 1Statewide Wellness Awards Competition Now Open for Nominations 22794 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 1BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 3BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2524 4
...FirstCall/ -- Sosei Group,Corporation , a biopharm...completion of a study of its fentanyl sublingual s...nt of cancer,breakthrough pain. , This was a pharm...le dose, cross-over, randomised study of AD 923 ve...lozenge) and versus fentanyl,citrate injection. Th...
...wire/ -- Results from analyses,looking at factor...tive colitis (UC), were presented at Digestive Dis... were funded by Procter &,Gamble (P&G) Pharmaceu...nformation on improvement of quality of life for U...which is from a class,of agents known as 5-ASAs....
Other Medicine Technology:Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 2Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 3Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 4Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 5
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: